Episodes
On this episode, I discuss timolol pharmacology, adverse effects, drug interactions, and much more.
Timolol is a non-selective beta-blocker so it blocks both beta-1 and beta-2 receptors.
Since timolol blocks beta-2 receptors, it can blunt the effect of respiratory medications that have beta-agonist action.
Beta-blockers are notorious for causing bradycardia and pulse is an important monitoring parameter for timolol.
Published 05/30/24
Continuous Glucose Monitors (CGMs) are becoming an important tool in the management of diabetes. I break down some of the most common clinical practice pearls you should know.
Published 05/23/24
On this episode of the Real Life Pharmacology Podcast, I cover some of the most common food and supplement drug interactions.
The 3 G's can potentially increase the risk of bleeding in patients on anticoagulants and antiplatelets. I discuss what supplements these are.
There are some vitamins that can cause drug interactions. Vitamin C is a supplement that can alter the absorption of some medications.
Metal cations like iron can bind certain medications and reduce...
Published 05/16/24
On this episode, I discuss the new medication vonoprazan and where it will likely be used in practice.
Vonoprazan is from a brand new class of medication called "PCAB". I discuss this medication and its pharmacology in this podcast episode.
Drug interactions and cost are the two major downsides of this medication that will likely limit its use compared to the PPIs.
CYP3A4 inducers like rifampin, carbamazepine, and phenytoin should not be used with vonoprazan. They will...
Published 05/09/24
Today’s sponsor of the 10 Commandments of Polypharmacy podcast is FreedAI. Freed listens, transcribes, and writes medical documentation for you.
FreedAI is offering a discount exclusive to RLP listeners! Users will get $50 off their first month with Freed! Use the discount code: RLPPOD
Here is part 2 of 2 on the final 5 of the 10 commandments of polypharmacy.
6. Thou shalt identify limits for medications not intended for chronic use as well as not continue a medication...
Published 05/02/24
On this special episode, I provide some real-life examples and layout 5 of my 10 commandments of polypharmacy.
Today’s sponsor of the 10 Commandments of Polypharmacy podcast is FreedAI. Freed listens, transcribes, and writes medical documentation for you.
FreedAI is offering a discount exclusive to RLP listeners! Users will get $50 off their first month with Freed! Use the discount code: RLPPOD
Here are the first 5 commandments that are addressed in the podcast....
Published 04/25/24
Today’s sponsor of the Top 10 Anticoagulant Drug Interactions podcast is FreedAI. Freed listens, transcribes, and writes medical documentation for you.
FreedAI is offering a discount exclusive to RLP listeners! Users will get $50 off their first month with Freed! Use the discount code: RLPPOD
Apixaban is one of the most commonly used anticoagulants and there are some drug interactions you need to be aware of. Take a listen and find out!
Warfarin concentrations can...
Published 04/18/24
Today's sponsor of the Top 10 SSRI Drug Interactions podcast is FreedAI. Freed listens, transcribes, and writes medical documentation for you.
FreedAI is offering a discount exclusive to RLP listeners! Users will get $50 off their first month with Freed! Use the discount code: RLPPOD
In this podcast episode, I discuss how to navigate SSRI drug interactions and identify some of the most common medications that have additive serotonergic activity.
SSRIs have antiplatelet...
Published 04/11/24
On this episode, I discuss travoprost pharmacology, adverse effects, administration, and much more on this podcast episode.
Travoprost is used to reduce intraocular pressure in the management of glaucoma. I discuss the mechanism of action and adverse effects.
Travoprost is a prostaglandin analog that can help reduce intraocular pressure and reduce the risk of the potential complication of blindness.
Growth of eyelashes is a unique adverse effect associated with...
Published 04/04/24
On this podcast episode, I finish up my breakdown of the Beers Criteria.
I cover the use of sliding-scale insulin and sulfonylureas in geriatric patients. Hypoglycemia is a major concern with both of these diabetes management strategies.
PPIs show up on the Beers criteria list as they can increase the risk of C. diff, pneumonia, fractures, and GI malignancies.
Metoclopramide has dopamine antagonist activity and can increase the risk of EPS and tardive dyskinesia.
Published 03/28/24
In this podcast episode, I break down some of the most common medications that show up on the Beers criteria list.
I discuss cardiovascular medications in this podcast episode, including rivaroxaban and warfarin, and why they show up on the Beers list.
Alpha-blockers who up on the Beers list as these medications are inappropriate to use for the management of hypertension.
The Beers criteria addresses the use of aspirin in primary prevention. I break down what the...
Published 03/21/24
On this episode, I discuss the pharmacology surrounding QTc prolongation and drug interactions.
I discuss which medications are more likely to cause QTc prolongation and which patient populations we should be more concerned about.
Antiarrhythmics are a common class of medication that can exacerbate QTc prolongation when used with other interacting medications.
500 ms is a common value utilized to help identify patients at risk for QTc prolongation and ultimately...
Published 03/14/24
On this podcast episode, I cover risedronate pharmacology, adverse effects, drug interactions, and much more.
There is a strict administration procedure with risedronate which is designed to reduce adverse effects and enhance absorption. I discuss this in the podcast.
Many medications may cause osteoporosis and may precipitate treatment with risedronate. Corticosteroids and excessive thyroid hormone replacement are two examples.
Patients should remain upright (sitting...
Published 03/07/24
On this podcast episode, I discuss some of the most common antihypertensive drug interactions you need to know.
One major interaction I discuss is the trifecta of a diuretic, an ACE or ARB, and an NSAID. This combination significantly increases the risk for acute renal failure.
Nitrates aren't classically referred to as an antihypertensive but they can definitely cause some problems when combined with PDE5 Inhibitors.
Lithium can interact with 3 blood pressure...
Published 02/29/24
Teplizumab is a relatively new agent that helps delay the progression of type 1 diabetes. It slows the rate of beta-cell destruction in the pancreas.
Teplizumab is associated with cytokine release syndrome which can result in flu-like symptoms of fever, aches, and headache.
Cytokine release syndrome due to teplizumab can be reduced by using appropriate pretreatment medications. Those medications can include analgesics, antihistamines, and/or antiemetics.
Teplizumab is...
Published 02/22/24
On this podcast episode, I discuss captopril pharmacology, kinetics, interactions, and much more!
Captopril is an ACE Inhibitor. It can cause hyperkalemia, cough, and renal impairment.
One of the notable issues with captopril is its relatively short half-life which requires it to be dose frequently throughout the day.
Lithium is an important drug interaction and the use of captopril with this medication may increase concentrations and the chance for toxicity.
Published 02/15/24
On this episode of the Real Life Pharmacology podcast, I take a dive into the most common mechanisms of drug interactions. Below I list some of the common drug interactions seen in practice and how they work!
Opposing Effects
Many drugs will work on various receptors throughout the body. To use as an educational point, there is no better example to point to than the beta receptor. Beta-blockers are frequently used in clinical practice for their ability to lower blood pressure...
Published 02/08/24
On this podcast episode, I discuss insulin aspart pharmacology, adverse effects, drug interactions, and much more.
Insulin apart is a rapid acting insulin product meant to bring down blood sugars quickly (most often after meals).
It is important to remember a couple of medications that may counteract the effects of insulin and apart and raise blood sugar. I talk about corticosteroids and thiazide diuretics in the drug interaction section.
Fiasp is a slightly modified...
Published 02/01/24
On this podcast episode, I discuss gentamicin pharmacology, adverse effects, monitoring, drug interactions and much more!
Drug monitoring is critical with gentamicin. Trough and peak concentrations can guide therapy and identify someone at risk of toxicity.
Nephrotoxicity is a major concern with gentamicin. There are numerous nephrotoxic agents that can increase this risk. I discuss them on the podcast.
Ototoxicity is another risk associated with gentamicin. Loop...
Published 01/25/24
On this podcast episode, I discuss fenofibrate pharmacology, adverse effects, kinetics, drug interactions, and much more!
Fenofibrate is typically only used for hypertriglyceridemia. The primary risk of hypertriglyceridemia is pancreatitis so we treat these levels because of this risk.
LFTs elevation has been associated with fenofibrate use as well as myopathy. In the presence of myopathy, checking CPK may be considered.
Fenofibrate is a weak CYP2C9 inhibitor. Warfarin...
Published 01/18/24
On this podcast episode, I discuss levofloxacin pharmacology, adverse effects, boxed warnings, interactions, and much more.
Levofloxacin is well known to cause QTc prolongation and many drugs can increase this risk such as antiarrhythmics, citalopram, antipsychotics, and many more.
Binding interactions are important when discussing levofloxacin pharmacology. Calcium, iron, magnesium, and many other cations can block the absorption of this medication.
I discuss tendon...
Published 01/11/24
On this podcast episode, I discuss darifenacin pharmacology, adverse effects, drug interactions and much more.
CYP3A4 and CYP2D6 are important enzymes in relation to darifenacin. I breakdown the importance of these enzymes and how they can impact drug therapy.
Darifenacin has anticholinergic activity but affects the central nervous system less than other agents in its class such as oxybutynin and tolterodine.
Darifenacin's pharmacology is selective for the Muscarinic-3...
Published 01/04/24
In this podcast episode, I discuss naltrexone pharmacology, adverse effects, drug interactions, and much more.
Naltrexone is an opioid antagonist and can blunt the effects of opioid agonists. Because of this, the medication can be used to manage opioid use disorder.
Hepatotoxicity is a concern of naltrexone and because of this, it is recommended to monitor LFTs.
There is an injectable, long-acting formulation of naltrexone that can be used for opioid and alcohol use...
Published 12/28/23
On this podcast episode, I discuss acamprosate pharmacology, adverse effects, drug interactions, and much more!
Acamprosate's most common adverse effect is diarrhea. It is a primary reason why patients will ask to stop taking this medication.
It is critical to assess renal function prior to using acamprosate. Dose adjustments are recommended when patients have a CrCl of less than 50 ml/min.
Unlike naltrexone, acamprosate avoids liver metabolism making it an alternative...
Published 12/21/23
On this podcast episode, I discuss alfuzosin pharmacology, adverse effects, drug interactions, and much more!
Alfuzosin is an alpha blocker used to help relieve the symptoms of BPH.
Low blood pressure is a possible adverse effect of alfuzosin and is more likely when combined with PDE-5 inhibitors like sildenafil.
CYP3A4 is an important enzyme in the metabolism of alfuzosin. Inhibitors of CYP3A4 can raise concentrations and increase the chance of alfuzosin toxicity.
Published 12/14/23